The 4th Annual Conference in Japan for Asian New Drug Development

The third conference for Asian new drug development was held in Tokyo in May, 2009. Several issues about Asian development were discussed intensively from the sponsor’s and the regulatory reviewer’s point of view.

For the fourth conference, the program committee has been joined by colleagues from East Asian countries – China, the Republic of Korea, Taiwan, and Japan – who are actively involved in drug development in Asia. The more critical topics have been selected.

Main topics are as follows:

1)      Asian clinical trials in oncology area (development strategy and operation)

2)      Simultaneous global development from East Asia point of view

3)      Ethnic similarity and differences among East Asia (medical practices, PK etc.)

This program will benefit the following individuals:

·         Clinical development professionals

·         Personnel involved in regulatory affairs

·         Personnel at clinical study sites

·         Personnel at CROs and SMOs

For meeting and exhibit information, contact:

The Drug Information Association, LLC office in Tokyo by telephone +81-(0)3-5833-8444,

by fax +81-(0)3-5820-8448, by email diajapan@diajapan.org